Absent correlation between vaginal bleeding and oestradiol levels or endometrial morphology during tibolone use in early postmenopausal women

Maturitas

Volumn 35, Issue 1, 2000, Pages 81-88

  Berning, Bernd ^a   Van Kuijk, Cornelis ^a   Bennink, Herjan J T Coelingh ^b   Fauser, Bart C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NV ORGANON   (Netherlands)

Author keywords

Endometrial morphology; Oestradiol levels; Tibolone; Vaginal bleeding

Indexed keywords

ESTRADIOL; FOLLITROPIN; TIBOLONE;

ARTICLE; BONE ATROPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; FEMALE; FLUOROIMMUNOASSAY; HUMAN; HYPERCHOLESTEROLEMIA; MORPHOLOGY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; SKIN ALLERGY; VAGINA BLEEDING;

EID: 0034724882     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(00)00103-1     Document Type: Article

References (20)

1. F.P.M.J. Groeneveld F.P. Bareman R. Barentsen H.J. Dokter A.C. Drogendijk A.W. Hoes Duration of hormonal replacement therapy in general practice; a follow-up study Maturitas 29 1998 125 131
2. J. Visser A. Coert J. Vies van der Endocrinological studies with (17 alpha, 17 alpha)-17 hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14) Maturitas Suppl. 1 1987 15 24
3. R. Trevoux P. Dieulangard A. Blum Efficacy and safety of Org OD 14 in the treatment of climacteric complaints Maturitas 5 1983 89 96
4. L. Tax E.M. Goorissen P.M. Kicovic Clinical profile of Org OD 14 Maturitas Suppl. 1 1987 3 13
5. B. Berning C. von Kuijck J.W. Kuiper H.J.T. Coelingh Bennink P.M. Kicovic B.C.J.M. Fauser Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a 2-year double blind placebo-controlled study Bone 19 1996 395 399
6. N.H. Bjarnason K. Bjarnason J. Haarbo C. Rosenquist C. Christansen Tibolone: prevention of bone loss in late postmenopausal women J. Clin. Endocrinol. Metab. 81 1996 2419 2422
7. A.R. Gennazzani L.J. Benedek-Jaszman D.M. Hart L. Andolsel P.M. Kicovic L. Tax Org OD 14 and the endometrium Maturitas 13 1991 243 251
8. J. Rymer I. Fogelman M.G. Chapman The incidence of vaginal bleeding with tibolone treatment Br. J. Obstet. Gynecol. 101 1994 53 56
9. J. Ginsburg G.M. Prelevic D. Butler S. Okolo Clinical experience with tibolone (Livial) over 8 years Maturitas 21 1995 71 76
10. M. Habiba J. Ramsay A. Akkad D.M. Hart F. Al-Azzawi Immunohistochemical and hysteroscopic assessment of postmenopausal women with uterine bleeding whilst taking tibolone Eur. J. Obstet. Gynecol. Reprod. Biol. 66 1996 45 49
11. Lindsay R, McK Hart D, Kraszewski A. Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis. Br Med J 1980;280:1207–1209.
12. B. Berning C. van Kuijk H.E. Schütte J.W. Kuiper A.C. Drogendijk B.C.J.M. Fauser Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography Bone Miner. 21 1993 129 139
13. S. Alberico A. Elia L. Dal Corso G.P. Mandruzzato L. Di Bonito S. Patriarca Diagnostic validity of the Vabra Curettage of the uterine cavity Eur. J. Gynaecol. Oncol. 7 1986 135 138
14. J. Vies van der Pharmacological studies with (7 alpha,17 alpha)-17-hydroxy-7-methyl-19-norpregn-5(10)-en-20-yn-3-one (Org OD 14) Maturitas Suppl. 1 1987 15 24
15. L. Markiewicz E. Gurpide Estrogenic and progestagenic activities coexisting in steroidal drugs: quantitative evaluation by in vitro bioassays with human cells J. Steroid Biochem. Mol. Biol. 48 1994 89 94
16. G.W. Sandker R.M.E. Vos L.P.C. Delbressine M.J.H. Slooff D.K.F. Meijer G.M.M. Groothuis Metabolism of three pharmacologically active drugs in isolated human and rat hepatocytes: analysis of interspecies variability and comparison with metabolism in vivo Xenobiotica 24 1994 143 155
17. B. Tang L. Markiewics H.J. Kloosterboer E. Gurpide Human endometrial 3 beta-hydroxysteroı̈d dehydrogenase/isomerase can locally reduce intrinsic estrogenic/progestagenic activity ratios of a steroı̈dal drug (Org OD 14) J. Steroid Biochem. Mol. Biol. 45 1993 345 351
18. L. Markiewicz E. Gurpide In vitro evaluation of estrogenic, estrogen antagonistic and progestagenic effects of a steroidal drug (Org OD-14) and its metabolites on human endometrium J. Steroid Biochem. 35 1990 535 541
19. J. Ginsburg G.M. Prelevic Cause of vaginal bleeding in postmenopausal women taking tibolone Maturitas 24 1996 107 110
20. Von Dadelszen P, Gillmer MDG, Gray MD, et al. Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy. Br J Obstet Gynecol 1994;101:158–161.